Boehringer Ingelheim Korea said it has commenced a voluntary recall of select batches for Spiriva Respimat (ingredient: tiotropium bromide hydrate), its chronic obstructive pulmonary disease (COPD) and asthma medication.This medication is approved for use as a bronchodilator in the maintenance treat
In a recent media session organized by MSD Korea, a local professor shared insights regarding the efficacy of MSD's Lagevrio (ingredient: molnupiravir) in treating Covid-19, with a particular focus on high-risk groups.As the global community continues to recover from the pandemic, the Covid-19 virus
Bayer Korea's treatment for chronic kidney disease with type 2 diabetes, Kerendia (finerenone), will be covered by health insurance for adult patients starting next month.Kerendia is a first-in-class non-steroidal selective antagonist of the mineralocorticoid receptor, a novel mechanism of action th
Dong-A Pharmaceutical said Tuesday that it has launched a seven-day supply of Orthomol Vital M (for men) and Orthomol Vital F (for women), premium vitamin supplements from German nutraceutical company Orthomol.Orthomol Vital is a nutraceutical brand officially imported and sold in Korea by Dong-A Ph
For the sustainable growth of the domestic biopharmaceutical industry, the government must reform regulations to facilitate businesses’ investment, an industry leader said on Tuesday.To this end, the design of a simple, clear, and predictable drug price system is essential, and the legal status of t
GC Biopharma said Tuesday that it launched a 30-tablet version of its anti-inflammatory drug, Tak-Sen soft cap (naproxen).Tak-Sen is an over-the-counter nonsteroidal anti-inflammatory drug (NSAID) for relieving inflammation and general pain, such as headaches and muscle aches.According to GC Biophar
Daewoong Pharmaceutical said Tuesday that its U.S. partner, AEON Biopharma, has confirmed the safety and efficacy of Daewoong's botulinum toxin (BTX), ABP-450, through phase 2 clinical trials in cervical dystonia and preclinical results in post-traumatic stress disorder (PTSD).AEON Biopharma, a U.S.
The phase 2 clinical trial for preoperative adjuvant therapy, examining the Keytruda-GX-188E-GX-I7/NT-I7 triple combination in the treatment of HPV (human papillomavirus type)-positive head and neck cancer, initiated in 2022, is set to expand to include 56 patients this year.Genexine and NeoImmuneTe
GC Wellbeing, a health/functional food manufacturer, said it signed a new export business agreement with YooYoung Pharmaceutical to enter the Chinese filler market.Under the accord, the two companies aim to develop, produce, market, and sell products specifically for the Chinese filler market, with
SK biopharmaceuticals announced its 2023 fourth quarter and annual financial results, highlighting significant revenue growth and a reduction in operating losses, thanks to increased sales of its epilepsy drug, cenobamate, and cost efficiency measures.The company's revenue for 2023 was 354.9 billion
Daewoong Pharmaceutical said Monday that its drug candidate for idiopathic pulmonary fibrosis (IPF), bersiporocin (DWN12088), has received orphan drug designation ODD) from the European Medicines Agency (EMA).Bersiporocin is a Prolyl-tRNA Synthetase (PRS) inhibitor drug candidate that reduces the ac
Korean biopharmaceutical companies drew attention by unveiling clinical trial results of anticancer drug candidates at ASCO Gastrointestinal Cancers Symposium (ASCO GI) being held in San Francisco, Calif., Jan. 18 to 20.The anticancer drug candidates developed by Idience, AbClon, Genome & Company, a
Daehwa Pharm, a Kosdaq-listed drugmaker, announced Monday that it has garnered a favorable opinion from the Committee for Medicinal Products for Human Use (COMP) of the European Medicines Agency (EMA) for orphan drug designation (ODD) for its oral paclitaxel formulation, Liporaxel Sol, as a second-l
Celltrion said Monday that it has submitted a marketing authorization application to the U.S. FDA for CT-P47, a biosimilar to Roche’s Actemra (tocilizumab) for the treatment of autoimmune diseases.Based on the global phase 3 results of CT-P47, which included 471 patients with rheumatoid arthritis (R
JW Pharmaceutical said Thursday that it has launched a reduced-size version of its high-dose ibuprofen nonsteroidal anti-inflammatory drug (NSAID), Pain Angel Ibu Soft Cap, to make it more convenient.Pain Angel Ibu is a high-dose pain reliever that contains 400 mg of ibuprofen per tablet.According t
Quratis said Friday that it has administered the first dose of schistosomiasis vaccine developed in collaboration with international organizations in Africa.The schistosomiasis vaccine has successfully completed a phase 1 clinical trial in the United States, and phase 1b dosing began in Africa in No
Genexine said it has completed the biologics license application (BLA) to the Ministry of Food and Drug Safety (MFDS) for Efesa (efepoetin alfa), its anemia treatment.Developed in collaboration with Kalbe through their joint venture, KGBio, Efesa is a third-generation treatment for renal anemia.Unli
Dongkook Pharmaceutical said Thursday that it has launched Memorain Cap., a memory and concentration enhancer composed of herbal medicine.According to Dongkook Pharm, Memorain is an herbal complex consisting of 100mg of 40 percent ethanol-dried ginseng and 60mg of ginkgo biloba extract, effectively
Huons said Friday that it has signed a memorandum of understanding on strategic material supply with MFC to develop new drugs.Under the MOU, Huons will receive high-quality raw materials for new drug development from MFC, including key pharmaceutical ingredients such as Ilaprazole, Gemigliptin, Vare
NeoImmuneTech said Thursday that NT-I7 (efineptakin alfa) has received orphan drug designation (ODD) from the U.S. Food and Drug Administration for pancreatic cancer.The FDA's orphan drug system is designed to facilitate the development and approval of drugs to treat rare diseases that affect 200,00